Executive Briefing
Schedule Executive Briefing
Organizations evaluating significant AI deployment investments often face AI Capital Risk.
AI Capital Risk is the risk of approving AI investment before the organization is ready to deploy it at scale.
Most teams complete the AI Capital Deployment Readiness Diagnostic first for authorization posture and ACRI. This briefing is for executive alignment on the full AI Capital Risk Instrument: scope, governance expectations, timeline, and board-ready deliverables.
Share a few details about your organization and the AI investment under consideration. We'll schedule a confidential conversation to discuss how Stratify surfaces risk before capital is committed.
No obligation. Confidential. Typically responds within 1 business day.
Start with the AI Capital Authorization Framework, review the AI Capital Authorization Benchmark Report, or inspect a sample AI Capital Authorization Report.
What Organizations Receive
AI Capital Authorization Report delivered in ~14 days
- Capital authorization posture
- Five-vector exposure diagnostics
- EU AI Act exposure overlay
- Stabilization pathway for constrained deployments
Delivered as a board-ready AI Capital Authorization Report used by boards and investment committees during AI capital authorization decisions.
Example Executive Determination from the AI Capital Authorization Instrument (ACRI).
Typical AI capital evaluated
$1M – $10M+
Used by boards and investment committees evaluating AI capital deployment.
Not ready to schedule yet?
You can review a representative AI Capital Authorization Report to see the output produced by the AI Capital Authorization Instrument (ACRI).
View Sample AI Capital Authorization Report